A court ruling that stops the European Medicines Agency from releasing data from two US companies calls into question the agency’s push for transparency.
A court ruling that stops the European Medicines Agency from releasing data from two US companies calls into question the agency’s push for transparency.
A recent roundtable discussion identifies challenges facing the scientific community regarding a lack of reproducible results in the literature.
The National Institutes of Health is launching a pilot program to introduce students to clinical and translational research.
A Swiss-based firm may have a back-door way to thwart a bioterrorist attack—by fighting the flu.
FDA points its finger at an early-stage contract research organization for falsifying documents and manipulating samples.
Page 1 of 1